piretanide has been researched along with Nephrotic Syndrome in 3 studies
piretanide: potent inhibitor of chloride transport; structure
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marone, C | 1 |
| Reubi, FC | 1 |
| Plum, J | 2 |
| Plum, F | 2 |
| Pooth, R | 2 |
| Grabensee, B | 2 |
3 other studies available for piretanide and Nephrotic Syndrome
| Article | Year |
|---|---|
Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndrome.
Topics: Body Water; Diuresis; Diuretics; Furosemide; Humans; Kidney Concentrating Ability; Kidney Tubules; L | 1980 |
[Clinical and pathophysiologic effects of piretanide in nephrotic syndrome].
Topics: Adult; Atrial Natriuretic Factor; Blood Volume; Catecholamines; Diuretics; Dose-Response Relationshi | 1992 |
Clinical and pathophysiological effects of piretanide treatment in the nephrotic syndrome.
Topics: Adolescent; Adult; Aldosterone; Atrial Natriuretic Factor; Diuretics; Female; Follow-Up Studies; Glo | 1991 |